Aonong Bio (603363.SH) released its semi-annual performance report, with a net profit attributable to the parent company of 361 million yuan, turning a loss into a profit year-on-year.

Wisdom Financial App news, Anovax Bioscience (603363.SH) disclosed its 2025 interim report, during the reporting period, the company achieved a revenue of 3.957 billion yuan, a year-on-year decrease of 15.01%; the net profit attributable to the parent company was 361 million yuan, turning losses into profits year-on-year; non-recurring net profit loss of 29.74 million yuan; basic earnings per share of 0.14 yuan.